California CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
California will Require State Approval on Virus Vaccines
Distribution of any new coronavirus vaccines in California will first require a review by a panel of the state’s own experts. California Governor Gavin Newsom on Monday named a group of 11 nationally acclaimed California physician scientists with expertise in immunization and public health to the state’s COVID-19 Scientific Safety Review Workgroup that will independently review the safety and efficacy of any vaccine that receives FDA approval for distribution.
Governor Newsom says, “Our response to COVID-19 has and will continue to lead with data and science including when it comes to COVID-19 vaccines. California leads in science and by bringing together our state’s brightest scientific minds, we can ensure that any vaccine distributed here meets safety requirements.”
The Scientific Safety Review Workgroup is a key piece of the state’s initial COVID-19 vaccine distribution plan, which was submitted to the Centers for Disease Control and Prevention. Many vaccine candidates are in clinical trials currently, and California is putting a system in place for the distribution and administration of vaccine as supply becomes available.
The governor added, “Recognizing that supplies will be limited initially and the first doses of vaccines must go to health care workers, first responders and others who are especially vulnerable to this disease, we are working to ensure that administration and distribution of an approved vaccine is equitable.”
The Scientific Safety Review Workgroup will be chaired by Dr. Arthur L. Reingold, the Division Head of Epidemiology and Biostatistics at the UC Berkeley, School of Public Health.
For comments, questions or concerns, please contact Dennis Kaiser
